These findings provide compelling evidence that TIMP3, BRAF, and ITGB1 may not only serve as prognostic biomarkers in HGSOC but also play a role in influencing ovarian cancer outcomes. This evidence concerns the gene TIMP3 and ovarian carcinoma.